Innoviva’s Entasis acquisition brings a novel antibiotic that’s ready for the FDA
Entasis Therapeutics is being acquired by Innoviva in a deal that brings an FDA-ready antibiotic developed to address drug-resistant strains of a bacterium that infects […]